Novel approaches to estimate prefrontal synaptic strength in vivo in humans: of relevance to depression, schizophrenia, and ketamine.

Subjects

Subjects :

Depression drug therapy
Humans
Prefrontal Cortex metabolism
Receptors, N-Methyl-D-Aspartate metabolism
Ketamine pharmacology
Schizophrenia drug therapy

Details

Language :

English

ISSN :

1740-634X

Volume :

47

Issue :

1

Database :

MEDLINE

Journal :

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Publication Type :

Periodical

Accession number :

34341492

Full Text :

https://doi.org/10.1038/s41386-021-01122-2